TransThera Sciences (Nanjing), Inc. (HKG:2617)
192.00
-2.20 (-1.13%)
At close: Dec 5, 2025
HKG:2617 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 449.07 | 569.51 | 496.63 | 983.93 |
| Short-Term Investments | 1.63 | 1.4 | 0.55 | 0.42 |
| Trading Asset Securities | 186.79 | 3.03 | 341.54 | - |
| Cash & Short-Term Investments | 637.49 | 573.93 | 838.72 | 984.35 |
| Cash Growth | -11.29% | -31.57% | -14.79% | - |
| Other Receivables | 0.45 | 0.46 | 0.6 | 1.05 |
| Receivables | 0.45 | 0.46 | 0.6 | 1.05 |
| Inventory | 0.25 | 0.17 | 0.16 | 0.25 |
| Other Current Assets | 10.9 | 10.69 | 6.12 | 176.67 |
| Total Current Assets | 649.09 | 585.25 | 845.6 | 1,162 |
| Property, Plant & Equipment | 26.34 | 28.77 | 31.62 | 14.5 |
| Other Intangible Assets | 0.58 | 0.71 | 0.98 | 1 |
| Other Long-Term Assets | 16.86 | 14.87 | 8.89 | 11.83 |
| Total Assets | 692.86 | 629.6 | 887.09 | 1,190 |
| Accounts Payable | 87.17 | 81.24 | 78.58 | 72.24 |
| Accrued Expenses | - | 12.04 | 13.61 | 14.69 |
| Current Portion of Leases | 2.65 | 3.16 | 3.46 | 2.69 |
| Current Income Taxes Payable | - | 0.04 | 0.09 | 0.1 |
| Current Unearned Revenue | - | 6.4 | 6.4 | 6.6 |
| Other Current Liabilities | 20.44 | 0.48 | 0.43 | 0.75 |
| Total Current Liabilities | 110.25 | 103.36 | 102.56 | 97.06 |
| Long-Term Leases | 0.41 | 1.21 | 1.35 | - |
| Long-Term Unearned Revenue | - | - | - | 0.98 |
| Total Liabilities | 110.66 | 104.57 | 103.91 | 98.04 |
| Common Stock | 396.9 | 381.62 | 381.62 | 379.95 |
| Additional Paid-In Capital | - | 1,573 | 1,573 | 1,555 |
| Retained Earnings | -1,522 | -1,399 | -1,125 | -781.25 |
| Comprehensive Income & Other | 1,707 | -30.59 | -47.05 | -62.02 |
| Shareholders' Equity | 582.2 | 525.03 | 783.18 | 1,092 |
| Total Liabilities & Equity | 692.86 | 629.6 | 887.09 | 1,190 |
| Total Debt | 3.06 | 4.37 | 4.81 | 2.69 |
| Net Cash (Debt) | 634.43 | 569.56 | 833.91 | 981.66 |
| Net Cash Growth | -11.00% | -31.70% | -15.05% | - |
| Net Cash Per Share | 1.66 | 1.49 | 2.19 | 2.72 |
| Filing Date Shares Outstanding | 396.9 | 381.62 | 381.62 | 360.39 |
| Total Common Shares Outstanding | 396.9 | 381.62 | 381.62 | 360.39 |
| Working Capital | 538.84 | 481.89 | 743.04 | 1,065 |
| Book Value Per Share | 1.47 | 1.38 | 2.05 | 3.03 |
| Tangible Book Value | 581.63 | 524.32 | 782.2 | 1,091 |
| Tangible Book Value Per Share | 1.47 | 1.37 | 2.05 | 3.03 |
| Machinery | - | 28.82 | 28.73 | 28.38 |
| Construction In Progress | - | 3.52 | 2.9 | - |
| Leasehold Improvements | - | 5.68 | 5.68 | 5.67 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.